Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jorge F, Paniagua Solís"'
Autor:
Johanna Bernáldez-Sarabia, Andrea Figueroa-Montiel, Salvador Dueñas, Karla Cervantes-Luévano, Jesús A. Beltrán, Ernesto Ortiz, Samanta Jiménez, Lourival D. Possani, Jorge F. Paniagua-Solís, Jorge Gonzalez-Canudas, Alexei Licea-Navarro
Publikováno v:
Toxins, Vol 11, Iss 2, p 128 (2019)
Californiconus californicus, previously named Conus californicus, has always been considered a unique species within cone snails, because of its molecular, toxicological and morphological singularities; including the wide range of its diet, since it
Externí odkaz:
https://doaj.org/article/788bb7ca09db437e961116152664cde5
Publikováno v:
Toxins, Vol 9, Iss 3, p 74 (2017)
Scorpion stings on humans are medically relevant because they may contain toxins that specifically target ion channels. During antivenom production, pharmaceutical companies must use a large number of experimental animals to ensure the antivenom’s
Externí odkaz:
https://doaj.org/article/d168d76a8f5b4fb69d8c50bae25dbe06
Autor:
Pierrick G.J. Fournier, Robert M. Hoffman, Patricia L A Muñoz, Dalia Millán-Gómez, Jorge Gonzalez-Canudas, Olivia Cabanillas-Bernal, Marco A Ramos, Alexei F. Licea-Navarro, David Abia, Teresa Escalante, Noemi Sánchez-Campos, Salvador Dueñas, Almudena Perona, Carolina Elosua, Rosa E. Mares, Tanya A. Camacho-Villegas, Jorge F. Paniagua-Solís, Florian Drescher, Teresa Mata-Gonzalez
Publikováno v:
Oncotarget
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
The stability, binding, and tissue penetration of variable new-antigen receptor (VNAR) single-domain antibodies have been tested as part of an investigation into their ability to serve as novel therapeutics. V13 is a VNAR that recognizes vascular end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19201aa90774389493dfd0cd81448606
http://europepmc.org/articles/PMC6021326
http://europepmc.org/articles/PMC6021326
Autor:
Ernesto Ortiz, Johanna Bernáldez-Sarabia, Alexei F. Licea-Navarro, Jesus A. Beltran, Samanta Jiménez, Jorge Gonzalez-Canudas, Karla Cervantes-Luevano, Andrea Figueroa-Montiel, Jorge F. Paniagua-Solís, Salvador Dueñas, Lourival D. Possani
Publikováno v:
Toxins
Volume 11
Issue 2
Toxins, Vol 11, Iss 2, p 128 (2019)
Volume 11
Issue 2
Toxins, Vol 11, Iss 2, p 128 (2019)
Californiconus californicus, previously named Conus californicus, has always been considered a unique species within cone snails, because of its molecular, toxicological and morphological singularities
including the wide range of its diet, since
including the wide range of its diet, since
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b8846c12121688e76369701978b0481
https://doi.org/10.3390/toxins11020128
https://doi.org/10.3390/toxins11020128
Autor:
A. X. Martínez-Velázquez, A. Díaz-Quiñonez, R. Márquez-Velasco, Luis M. Amezcua-Guerra, Rafael Bojalil, F. Flores-Guzmán, Jorge F. Paniagua-Solís, F. Massó
Publikováno v:
Inflammation Research. 60:947-953
To assess the impact of different doses of anti-interferon gamma (anti-IFNγ) F(ab')2 fragments, administered prophylactically, on survival and on serum concentration of cytokines in a murine model of sepsis induced by cecal ligation and puncture (CL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f932d8357f650585589bfed4246bd91
https://doi.org/10.1007/s00011-011-0355-0
https://doi.org/10.1007/s00011-011-0355-0
Autor:
Walter Garcia-Ubbelohde, Alejandro Alagón, Carlos Sevcik, Alfredo Luis Chávez-Haro, Jorge F. Paniagua-Solís, Hilda Vázquez
Publikováno v:
International Immunopharmacology. 10:1318-1324
This paper presents the first study of F(ab')(2) scorpion antivenom pharmacokinetics in humans after intramuscular (im) administration. The specific anti-Centruroides scorpion antivenom was used in 6 human healthy volunteers. The fabotherapeutic was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cd16259a1bd00018acb9e892bd734f
https://doi.org/10.1016/j.intimp.2010.08.018
https://doi.org/10.1016/j.intimp.2010.08.018
Autor:
María Teresa Mata-González, Jorge F. Paniagua-Solís, Carolina Elosua, Linda Nuñez-Garcia, Walter García-Ubbelohd, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas
Publikováno v:
Marine Drugs, Vol 16, Iss 4, p 113 (2018)
Marine Drugs; Volume 16; Issue 4; Pages: 113
Marine Drugs
Marine Drugs; Volume 16; Issue 4; Pages: 113
Marine Drugs
Variable new antigen receptor domain (vNAR) antibodies are novel, naturally occurring antibodies that can be isolated from naïve, immune or synthetic shark libraries. These molecules are very interesting to the biotechnology and pharmaceutical indus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45be03e90ab7fe5ac97154b707d6a0fc
https://doi.org/10.3390/md16040113
https://doi.org/10.3390/md16040113
Publikováno v:
International Immunopharmacology. 10:447-454
We describe the separation of whole IgG, IgG(T)-less IgG (called here merely IgG) and IgG(T) and the production of Fab and F(ab')(2) fragments. We studied the pharmacokinetics of these immunoglobulins and fragments in rabbits. Both, the isotypes and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cdfa1f02a6ac07afc241472bd02b57e
https://doi.org/10.1016/j.intimp.2010.01.005
https://doi.org/10.1016/j.intimp.2010.01.005
Autor:
Alejandro Alagón, Roberto P. Stock, Adolfo R. de Roodt, Andrea Casasola, Blanca Ramos-Cerrillo, Guadalupe Guzmán, Jorge F. Paniagua-Solís, Laura Olguín, Jean-Philippe Chippaux
Publikováno v:
Toxicon. 52:881-888
As a response to the antivenom shortage in Sub-Saharan Africa, evident for well over a decade, we developed a new polyvalent anti-ophidian antivenom (Antivipmyn((R)) Africa) designed for use in the region. We report a detailed characterization of its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a83ae3dcf7bac14ba125463e7b77750
https://doi.org/10.1016/j.toxicon.2008.09.002
https://doi.org/10.1016/j.toxicon.2008.09.002
Autor:
A. Díaz-Quiñonez, Jorge F. Paniagua-Solís, J. Laguna, A. Buelna, F. Flores-Guzmán, R. Márquez-Velasco, Rafael Bojalil, A. M. Hernández, J. Estevez-Ramirez
Publikováno v:
Inflammation Research. 55:378-384
Negative results are frequent using anti-TNFalpha antibodies in sepsis models and clinical trials.Different prophylactic doses of anti-TNFalpha F(ab')2 antibody fragments were compared for the prevention of death by sepsis induced by cecal ligation a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::089ce6fa6fcf3fe882425e970eaf6b6d
https://doi.org/10.1007/s00011-006-6001-6
https://doi.org/10.1007/s00011-006-6001-6